29 June 2012
Anemia in solid organ transplantation
Jolanta Małyszko, Bruno Watschinger, Piotr Przybyłowski, Magdalena DurlikDOI: 10.12659/AOT.883227
Ann Transplant 2012; 17(2): 86-100
Abstract
Anemia is not only a feature of chronic kidney disease of native or grafted kidneys, but also is frequently found in liver and heart transplant recipients. End-stage organ failure requiring transplantation is usually associated with failure or impaired function of other organs. Chronic kidney disease developing after non-renal solid organ transplantation is a significant issue, as reviewed previously. The degree of functional impairment in kidney function after non-solid organ transplantation and the rate of progression of CKD post-transplant depend to a large extent on pretransplant kidney function (ie, stage of preexisting CKD), the type of the transplanted organ, and the immunosuppressive protocol (use of calcineurin inhibitors), presence of comorbid conditions such as diabetes, hypertension, HCV infection, older age, surgical issues, and individual clinical features determining susceptibility to renal injury, even nephropathy resulting from BK virus infection, is presented.
Keywords: Heart Transplantation, Anemia, liver, Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






